BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16467448)

  • 1. Podocyte cell-specific expression of doxycycline inducible Cre recombinase in mice.
    Juhila J; Roozendaal R; Lassila M; Verbeek SJ; Holthofer H
    J Am Soc Nephrol; 2006 Mar; 17(3):648-54. PubMed ID: 16467448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-specific expression of tamoxifen-inducible Cre recombinase in mice.
    Yokoi H; Kasahara M; Mukoyama M; Mori K; Kuwahara K; Fujikura J; Arai Y; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Nephrol Dial Transplant; 2010 Jul; 25(7):2120-4. PubMed ID: 20150167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte-specific expression of cre recombinase in transgenic mice.
    Moeller MJ; Sanden SK; Soofi A; Wiggins RC; Holzman LB
    Genesis; 2003 Jan; 35(1):39-42. PubMed ID: 12481297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal control of Cre recombinase-mediated in vitro DNA recombination by Tet-on gene expression system.
    Guo ZM; Xu K; Yue Y; Huang B; Deng XY; Zhong NQ; Hong X; Chen XG; Xiao D
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):133-8. PubMed ID: 15685371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction.
    Belteki G; Haigh J; Kabacs N; Haigh K; Sison K; Costantini F; Whitsett J; Quaggin SE; Nagy A
    Nucleic Acids Res; 2005 Mar; 33(5):e51. PubMed ID: 15784609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice.
    Utomo AR; Nikitin AY; Lee WH
    Nat Biotechnol; 1999 Nov; 17(11):1091-6. PubMed ID: 10545915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transgenic mouse that targets the expression of Cre recombinase in pancreatic tissue.
    Zhou J; Cheng X; Lu YX; Huang CF; Yang X
    Sheng Wu Gong Cheng Xue Bao; 2002 May; 18(3):286-90. PubMed ID: 12192858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelium-specific Cre recombinase activity in flk-1-Cre transgenic mice.
    Licht AH; Raab S; Hofmann U; Breier G
    Dev Dyn; 2004 Feb; 229(2):312-8. PubMed ID: 14745955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A transgenic mouse that targets the expression of Cre recombinase in hepatocyte].
    Wang YL; Cheng X; Cui F; Cheng J; Lü YX; Yang X
    Zhonghua Gan Zang Bing Za Zhi; 2004 Mar; 12(3):163-6. PubMed ID: 15059303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular surface tissue morphogenesis in normal and disease states revealed by genetically modified mice.
    Kao WW
    Cornea; 2006 Dec; 25(10 Suppl 1):S7-S19. PubMed ID: 17001198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a transgenic mouse in which Cre recombinase is expressed under control of the type II collagen promoter and doxycycline administration.
    Grover J; Roughley PJ
    Matrix Biol; 2006 Apr; 25(3):158-65. PubMed ID: 16386413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a viral T2A-peptide based knock-in mouse model for enhanced Cre recombinase activity and fluorescent labeling of podocytes.
    Koehler S; Brähler S; Braun F; Hagmann H; Rinschen MM; Späth MR; Höhne M; Wunderlich FT; Schermer B; Benzing T; Brinkkoetter PT
    Kidney Int; 2017 Jun; 91(6):1510-1517. PubMed ID: 28187984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tetracycline-inducible bitransgenic Krt12rtTA/+/tet-O-LacZ mice.
    Chikama T; Hayashi Y; Liu CY; Terai N; Terai K; Kao CW; Wang L; Hayashi M; Nishida T; Sanford P; Doestchman T; Kao WW
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):1966-72. PubMed ID: 15914610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generalized tetracycline induced Cre recombinase expression through the ROSA26 locus of recombinant mice.
    Bäckman CM; Zhang Y; Malik N; Shan L; Hoffer BJ; Westphal H; Tomac AC
    J Neurosci Methods; 2009 Jan; 176(1):16-23. PubMed ID: 18801387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertoli and granulosa cell-specific Cre recombinase activity in transgenic mice.
    Lécureuil C; Fontaine I; Crepieux P; Guillou F
    Genesis; 2002 Jul; 33(3):114-8. PubMed ID: 12124943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A system for inducible gene expression in retinal ganglion cells.
    Kerrison JB; Duh EJ; Yu Y; Otteson DC; Zack DJ
    Invest Ophthalmol Vis Sci; 2005 Aug; 46(8):2932-9. PubMed ID: 16043868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens.
    Jin C; McKeehan K; Wang F
    Prostate; 2003 Oct; 57(2):160-4. PubMed ID: 12949940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a new-generation reverse tetracycline transactivator system for quantitative control of conditional gene expression in the murine lung.
    Duerr J; Gruner M; Schubert SC; Haberkorn U; Bujard H; Mall MA
    Am J Respir Cell Mol Biol; 2011 Feb; 44(2):244-54. PubMed ID: 20395635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel technique for temporally regulated cell type-specific Cre expression and recombination in the pituitary gonadotroph.
    Naik K; Pittman I; Wolfe A; Miller RS; Radovick S; Wondisford FE
    J Mol Endocrinol; 2006 Aug; 37(1):63-9. PubMed ID: 16901924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional gene activation in cultured hepatocytes using a ligand-dependent chimeric Cre recombinase.
    Zhu HZ; Cao YY; Cheng GX; Xue JL
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 May; 35(5):435-40. PubMed ID: 12766804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.